Evaluation effects of Vitamin C and Ferrous Sulfate in Restless leg treatment of hemodialysis patients

Phase 2

Recruiting

• Conditions: Restless legs syndrome.; Other specified extrapyramidal and movement disorders; G25.8

• Registration Number: IRCT20100102002954N15
• Lead Sponsor: Vice chancellor for research; Shahroud University medical and Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 May 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Patients under regular hemodialysis
Age over 15 and under 70 years of patients
Definitive diagnosis of restless leg syndrome
No specific medication associated with restless leg therapy in the last two weeks
The absence of underlying disorders of the skeletal system
Having of satisfaction in research

Exclusion Criteria

Need to kidney transplant before study completion
Hyperparathyroidism
The presence of any underlying abnormalities of the skeletal system
Unstable of vital signs and hemodynamic
Dissatisfaction in research

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of Restless Leg Syndroum. Timepoint: Once a Month. Method of measurement: Standard Questioner of Restless Leg syndrome evaluation.